1Klein WM, van der Graaf Y, Seegers J, et al. Long - term cardiovascular morbidity, mortality, and reintervention after endovascular treatment in patients with iliac artery disease: The Dutch Iliac Stent Trial Study[J]. Radiology, 2004,232 ( 2 ) : 491-498.
2Schillinger M,Sabeti S, Loewe C,et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery[J]. N Engl J Med ,2006,354 ( 18 ) : 1879-1888.
3Hamsho A, Nott D, Harris PL. Prospective randomised trial of distal arte- riovenous fistula as an adjunct to femoro - infrapopliteal PTFE bypass [J]. Eur J Vasc Endovasc Surg,1999,17(3) :197-201.
5Shyu KG, Chang H, Wang BW, et al. Intramuscular vascular endothelial growth fact or gene therapy in patients with chronic critical leg ischemia [J]. Am J Med,2003,114(2) :85-92.
6Tateishi - Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb is chaemia by autologous transplantation of bonemarrow cells:a pilot study and a randomised controlled trial[J]. Lancet,2002,360(9331 ) :427-435.
7Dormandy JA,Rutherford RB.Management of peripheral arterial disease(PAD).TASC working group.trans Atlantic inter-society consensus(TASC)[J].J Vasc Surg,2000,31(1Pt 2):S1-S296.
8Klinkert P,Post PN,Breslaul PJ,et al.Saphenous vein versus PTFE for above-knee femoropopliteal bypass.A review of the literature[J].Eur J Vasc Endovasc Surg,2004,27(4):357-362.
9Walker SR,Yusuf SW,Hopkinson BR.A 10-year follow-up of patients presenting with ischaemic rest pain of the lower limbs[J].Eur J Vasc Endovasc Surg,1998,15(6):478-482.
10Norgren L, Hiatt WR, Dormandy JA, et al. Inter - society consensus for the management of peripheral arterial disease ( TASC lI) [ J ]. J Vasc Surg, 2007,45 (Suppl) :5 - 67.
